Lori Lopresti-Morrow

Lori Lopresti-Morrow has over 30 years of experience in the field of research and development. Lori'smost recent role was as a Research Scientist at Cybrexa Therapeutics, where they played a key role in developing a new class of therapeutics that target the tumor microenvironment. Lori also served as the IACUC Chair at the company. Prior to that, they worked as a Research Scientist at Kleo Pharmaceuticals Inc. from 2016 to 2017. Lori also worked at Kolltan Pharmaceuticals, Inc. as a Research Scientist III from 2011 to 2016. Before their time at Kolltan Pharmaceuticals, they held various positions at Pfizer Global Research & Development, starting as a Scientist in 1991 and eventually becoming a Senior Scientist from 2009 to 2011. Lori'scareer started at Hershey Medical Center, Penn State, where they worked as a Senior Research Technician from 1986 to 1991.

Lori Lopresti-Morrow holds a Master's degree in Biology from Brown University, which they obtained in 1996. Lori also earned a Bachelor's degree in Microbiology from Penn State University, although the exact dates of their enrollment and completion are unknown. Additionally, they completed a Regulatory Affairs Essentials Certificate from the University of California San Diego during the academic year of 2011-2012.